C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/63 (2006.01) A61K 45/00 (2006.01) A61P 3/04 (2006.01) A61P 3/06 (2006.01) A61P 3/08 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01) A61P 29/00 (2006.01) A61P 43/00 (2006.01) C07K 14/47 (2006.01) C12N 15/09 (2006.01) C12Q 1/02 (2006.01) C12Q 1/68 (2006.01) G01N 33/15 (2006.01) G01N 33/50 (2006.01) G01N 33/566 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2499791
The present invention relates to ANGPTL4 as biomarkers for PPARdelta activity, and to methods of diagnosing a disease linked to dysregulation of PPARdelta activity such as for example dyslipidemia, obesity or insulin resistance, methods of monitoring the treatment of patients suffering from a disease linked to dysregulation of PPARdelta activity and methods of identifying compounds which modulate PPARdelta activity.
Clerc Roger G.
Ebeling Martin
Gardes Christophe
Meyer Markus
Wright Matthew Blake
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Angptl4/fiaf as marker for ppardelta modulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angptl4/fiaf as marker for ppardelta modulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angptl4/fiaf as marker for ppardelta modulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1949785